All Investments

Advanced Digital Internet Corp.

Residential Internet access service provider to apartment buildings, cooperatives and condominiums.

Akebia Therapeutics

Clinical stage biopharmaceutical drug developer for anemia and peripheral vascular disease indications. Learn more at www.akebia.com

Alloptic, Inc.

Access network equipment provider offering state-of-the-art, optical IP Ethernet solutions. Learn more at www.alloptic.com

Analect Instruments

In-process spectroscopy instrumentation based on FTIR and Raman technologies for the petroleum and chemical processing industries.

Archemix Corp.

Biotech developer of proprietary platform of aptamer therapeutics. Learn more at www.archemix.com

Asset Management Outsourcing, Inc.

Provider of accounts receivable management services.

Baxano

Spinal surgery device developer of innovative solutions that restore spine function, preserve healthy tissue, and enable a better quality of life for patients. Learn more at www.baxano.com

Candera

Storage controller, device, systems and serial ATA (S-ATA) appliance & products.company.

Chaparral Network Storage, Inc.

Designer and marketer of storage appliances that facilitate movement of data between storage devices. Acquired by Dot Hill Systems (NASDAQ: HILL).

Comet Solutions, Inc.

Innovative provider of software for fast concept modeling early in the product design cycle. Learn more at www.cometsolutions.com

Cyber-Rain, Inc.

Provider of smart sprinkler control systems to light commercial users and municipalities, saving 30-70 percent on landscape watering bills via personal computer and automatic internet weather updates. Learn more at www.cyber-rain.com

DiAthegen

Early-stage biopharmaceutical developer of therapeutic & diagnostic products based on gene and protein technologies. Learn more at www.diathegen.com

Manta Media , Inc.

Online media company which provides the largest free source of information on small companies worldwide, enabling business professionals to promote their companies, sell faster and make business connections. Learn more at www.manta.com

Integrated Energy Services, Inc.

Commercial and industrial HVAC markets company.

Intellispace, Inc.

Early Ethernet IP-based service provider of ultra-high-speed bandwidth to US and UK-based businesses in commercial office buildings.

LigoCyte Pharmaceuticals

Specialty pharmaceutical vaccine developer of a new generation of vaccines and monoclonal antibody therapeutics for the prevention and treatment of infectious diseases and inflammation. Learn more at www.ligocyte.com

Micromet, Inc.

(NASDAQ: MITI)

Biopharmaceutical developer of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Learn more at www.micromet.de

PacketMotion, Inc.

Provider of security and compliance solutions for the Fortune 2000. The company enables IT professionals to see and control transactions on their networks in real time thereby safeguarding businesses against security threats. Learn more at www.packetmotion.com

Pain Therapeutics, Inc.

(NASDAQ: PITE)

Biopharmaceutical developer of novel drugs for pain management and hematology/oncology. Learn more at www.paintrials.com

Phobos Corporation

Developer of internet security and enterprise switching products. Acquired by SonicWALL (NASDAQ: SNWL).

Sendio

Innovative enterprise messaging security and anti-spamming Sender Address Verification technology. Learn more at www.sendio.com

Servion Global Solutions

Business response systems and solutions company, delivering software products and IT services to local and global customers across numerous industries relying on high quality customer interaction. Learn more at www.servion.com

StorageApps, Inc.

Data storage appliance company with advanced storage area network (SAN) virtualization technology. Acquired by Hewlett-Packard (NYSE: HPQ).

Verus Pharmaceuticals

Branded specialty pharmaceuticals company with a pediatric orientation. Learn more at www.veruspharm.com

Windy Hill Medical, Inc.

Specialty pharmaceuticals oncology developer of a novel approach to breast cancer therapy, adding new therapeutic options for women at risk.